Golden State Equity Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Golden State Equity Partners's LLY Position: Q3 2026 in Review
Golden State Equity Partners increased its Eli Lilly (LLY) stake by 282,900% in Q3 2026, buying an estimated $10M and bringing the position to 8,490 shares worth $9.8M. The position accounts for 0.58% of the portfolio, ranked #27.
Golden State Equity Partners first reported a position in LLY in Q4 2020 and has held it in 20 quarters since. 4,608 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Golden State Equity Partners held 8,490 shares of Eli Lilly worth $9.8M as of Q3 2026.
- Golden State Equity Partners bought 8,487 Eli Lilly shares in Q3 2026, an estimated $10M.
- Eli Lilly made up 0.58% of Golden State Equity Partners's portfolio in Q3 2026, its #27 holding.
- Golden State Equity Partners first reported a position in Eli Lilly in Q4 2020 and has held it in 20 quarters since.
- 4,608 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Golden State Equity Partners's 13F filing for Q3 2026, filed 3 Nov 2026.